CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company
Serina Therapeutics, Inc.
Sign in to watch- Ticker
- SER
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- AL
- Entity type
- operating
- EIN
- 821436829
- Phone
- (256) 327-9630
- Business address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Former names
- AgeX Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-23 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +4,100 | $0.06 | $246 | 4,100 |
| 2025-12-23 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −4,100 | $2.60 | $11K | 0 |
| 2025-12-23 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −4,100 | 352,186 | ||
| 2025-12-22 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +5,673 | $0.06 | $340 | 5,673 |
| 2025-12-22 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −5,673 | $2.67 | $15K | 0 |
| 2025-12-22 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,673 | 356,286 | ||
| 2025-12-16 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +3,227 | $0.06 | $194 | 3,227 |
| 2025-12-16 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −3,227 | $2.96 | $10K | 0 |
| 2025-12-16 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −3,227 | 361,959 | ||
| 2025-12-12 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +1,700 | $0.06 | $102 | 1,700 |
| 2025-12-12 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −1,700 | $3.26 | $6K | 0 |
| 2025-12-12 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −1,700 | 365,186 | ||
| 2025-12-11 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +3,555 | $0.06 | $213 | 3,555 |
| 2025-12-11 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −3,555 | $3.24 | $12K | 0 |
| 2025-12-11 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −3,555 | 366,886 | ||
| 2025-12-10 | Moreadith Randall Chief Scientific Officer | Grant or award 10b5-1 | +645 | $0.06 | $39 | 645 |
| 2025-12-10 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −645 | $3.35 | $2K | 0 |
| 2025-12-10 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −645 | 370,441 | ||
| 2025-12-09 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +600 | $0.06 | $36 | 600 |
| 2025-12-09 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −600 | $3.31 | $2K | 0 |
Page 4 of 12 · 223 trades